In this study, we investigated the expression of IFN-γ and IL-23/Th17-related cytokines, IL-17, IL-23 and IL-22, in BCC and their modulation during IMQ 5% cream or MAL-PDT treatment. This evidence concerns the gene IL23A and skin basal cell carcinoma.